TURNER & Townsend has announced it has been appointed to support GlaxoSmithKline (GSK) with its capital portfolio management in Montrose.
The deal includes complete portfolio management of GSK’s key manufacturing facilities in the town. Turner & Townsend’s Scottish real estate team will provide concept/feasibility project management, as well as project controls (cost and planning).
As a global supplier to GSK, Turner & Townsend revealed it is already providing services including project and programme management, cost management and projects controls services both globally and UK-wide.
Daniel Boreham, director of life sciences, Turner & Townsend, said, “This appointment strengthens our long-standing relationship with GSK, whilst providing opportunity to venture into a new region and bring some of our global initiatives such as the benchmarking club which brings GSK together with other major pharmaceutical companies to share data and best practice from across the industry to improve project delivery.
“This commission with GSK, combined with our existing wealth of expertise in the life sciences sector both globally and across the UK, puts us in good stead to taking this next step into the Scottish regions, where we have great ambitions for the industry.”
